Skip to main content Back to Top


70% Dextrose Injection Large Volume Bags

Reason for the Shortage

    • Baxter had 70% dextrose 2,000 mL bags on shortage due to manufacturing delays.[1]
    • BBraun discontinued 70% dextrose in 1,000 mL glass bottles in 2016. The 70% dextrose 2,000 mL bags were on allocation due to increased demand.[2]
    • Pfizer had 70% dextrose 500 mL in 1000 mL partial fill bags on back order due to manufacturing delays.[4]

Available Products

    • 70% Dextrose injection, BBraun, 2000 mL bag, 4 count, NDC 00264-7387-50
    • 70% Dextrose injection, Baxter, 2000 mL bag, 6 count, NDC 00338-0719-06
    • 70% Dextrose injection, Pfizer, 2000 mL bag, 6 count, NDC 00409-7120-07
    • 70% Dextrose injection, Pfizer, 500 mL in 1000 mL partial fill bag, 12 count, NDC 00409-7918-19

Estimated Resupply Dates

    • Baxter has 70% dextrose 2,000 mL bags available.[1]
    • BBraun has 70% dextrose 2,000 mL bags available to current customers.[2]
    • Pfizer has 70% dextrose 2,000 mL bags and 500 mL in 1000 mL partial-fill bags available.[4]

Implications for Patient Care

    • Solutions of 70% dextrose are used to compound a variety items including specialized solutions for neonatal or pediatric patients and total parenteral nutrition (TPN).[3]


    1. Baxter (personal communication). March 8, July 21, and August 30, 2017.
    2. BBraun (personal communication). March 7, July 7, and August 28, 2017.
    3. Bbraun. 70% Dextrose Injection, USP [product information]. Bethlehem, PA: BBraun; 2015.
    4. Pfizer (website). March 9, April 18, July 7 and 21, September 1, and September 29, 2017.


Updated September 29, 2017 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. Created March 9, 2017 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins